# Characterizing the Host Response to Leptospirosis for Better Diagnosis and Prognosis - NIHFI

> **NCT06945822** · NA · NOT_YET_RECRUITING · sponsor: **Institut Pasteur** · enrollment: 450 (estimated)

## Conditions studied

- Leptospirosis

## Interventions

- **OTHER:** Blood sample
- **OTHER:** Urine Sample

## Key facts

- **NCT ID:** NCT06945822
- **Lead sponsor:** Institut Pasteur
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-06-01
- **Primary completion:** 2029-07-01
- **Final completion:** 2029-07-01
- **Target enrollment:** 450 (ESTIMATED)
- **Last updated:** 2025-04-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06945822

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06945822, "Characterizing the Host Response to Leptospirosis for Better Diagnosis and Prognosis - NIHFI". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06945822. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*